Newsletter
Newsletter Support JNS

Sheba Medical Center

Tel Aviv, April 4, 2021. Photo by Miriam Alster/Flash90.
Israel may have achieved herd immunity against COVID-19
With 56 percent of its citizens vaccinated and another 15 percent recovered, Israel may be the first country where people who are immune protect those who aren’t.
The Padeh Geriatric Rehabilitation Center at Sheba Medical Center at Tel Hashomer, Israel. Credit: David Shay via Wikimedia Commons.
For third year in row, Sheba Medical Center ranks as one of world’s ‘Top 10’ hospitals
“Newsweek” magazine’s annual “World’s Best Hospitals” survey cited its superior health care, medical innovation and cutting-edge research.
A COVID-19 injection is prepared at a vaccination center in South Tel Aviv, Feb 14, 2021. Photo by Tomer Neuberg/Flash90.
Israeli data shows one dose of Pfizer vaccine 85 percent effective over time
The Sheba Medical Center findings support the U.K.’s decision to delay the second dose, says Sheba deputy director general.
A staff member receives a second dose of Pfizer's BioNTech COVID-19 vaccine at the Sheba Medical Center at Tel HaShomer on Jan. 10, 2021. Photo by Miriam Alster/Flash90.
High level of antibodies after second dose of COVID-19 vaccine, Israeli study shows
Professor Gili Regev-Yochay of the Infectious Disease Epidemiology Unit at Sheba Medical Center at Tel HaShomer says it’s reasonable to assume that those who receive two doses will not be carriers or contagious.
Israelis receive a dose of Pfizer's COVID-19 vaccine at a Clalit Health Fund vaccination center in Jerusalem on Jan. 12, 2021. Photo by Yonatan Sindel/Flash90.
One dose of Pfizer’s vaccine cuts infection rate by a third after two weeks, finds study
The Clalit Health Fund study, which involved the testing of 200,000 Israelis age 60 and up, are in line with the pharmaceutical giant’s own research.
The coronavirus ward of the Kaplan Medical Center in Rehovot, on Dec. 11, 2020. Photo by Yossi Aloni/Flash90.
Israeli ventilation system could give COVID-19 the ‘smart’ treatment
The innovation is “nothing less than a game changer,” because it allows for monitoring several patients simultaneously, says Ori Efrati, director of the Pediatric Pulmonary Unit at the Sheba Medical Center.
The mission was initiated following an appeal from the governor of the Piedmont District to Israel’s ambassador to Italy, Dror Eydar.
Dr. Elhanan Bar-On, director of the Israel Center for Disaster Medicine and Humanitarian Response at Sheba Medical Center, goes wherever he’s needed.
The SARS-CoV-2 vaccine “BriLife,” developed by the Israel Institute of Biological Research, was administered to a 26-year-old volunteer, beginning the first of three stages of human testing.
Professor Eli Schwartz (center), flanked on the left by Eli Assolin, CEO and co-founder of Newsight Imaging, and on the right by Eyal Yatskan, CTO and co-founder of Newsight Imaging. Credit: Newsight Imaging.
Israeli hospital reports successful trials for saliva-based coronavirus test
Professor Eli Schwartz of the Center for Geographic Medicine and Tropical Diseases at the Sheba Medical Center reports a 95 percent accuracy rate in the nearly instant results.
“This is an expression of solidarity, to save the life of a baby is always the right thing to do,” says Israel’s Ambassador to Cyprus.
Unit 81 is working with the Sheba Medical Center to turn non-invasive ventilators that are commonly available into advanced hospital-grade ventilators, as Israel’s Ministry of Health orders its first 1,000 machines.